Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1682-1685

  Ishikawa, Toru ^a   Ichida, Takafumi ^a   Ishimoto, Yuiko ^a   Yokoyama, Junji ^a   Nomoto, Minoru ^a   Ebe, Yusuke ^b   Usuda, Hiroyuki ^b   Naito, Makoto ^b   Asakura, Hitoshi ^a  

^a Third Dept Int Med Niigata U   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TEGAFUR; TUMOR MARKER; URACIL;

AGED; ARTICLE; CANCER REGRESSION; CASE REPORT; DISEASE ASSOCIATION; DRUG FORMULATION; ENTERIC COATED TABLET; FEMALE; HEPATITIS C VIRUS; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NECROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTUM ULCER;

EID: 0032976481     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01163.x     Document Type: Article

References (14)

1. Kishi K., Shikata T., Hirohashi S., et al. Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases. Cancer. 51:1983;542-548.
2. Lee C.S., Sung J.L., Hwang L.Y., et al. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery. 99:1986;481-490.
3. Chen M.F., Hwang T.L., Jeng L.B., et al. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg. 124:1989;1025-1028.
4. Nagasue N., Kohno H., Chang Y.C., et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 217:1993;375-384.
5. Chuang V.P., Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology. 140:1981;51-58.
6. Nakamura H., Hashimoto T., Oi H., et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 170:1989;783-786.
7. Livraghi T., Festi D., Monti F., et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology. 161:1986;309-312.
8. Shiina S., Yasuda H., Muto H., et al. Percutaneous ethanol injection in the liver neoplasms. Am J Radiol. 149:1987;949-952.
9. Seki T., Wakabayashi M., Nakagawa T., et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 74:1994;817-825.
10. Murakami R., Yoshimatsu S., Yamashita Y., et al. Treatment of hepatocellular carcinoma Value of percutaneous microwave coagulation . Am J Roentgenol. 164:1995;1159-1164.
11. Wenqi J., Zhihong L., Youjian H., et al. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma Implication in 5-fluorouracil-based chemotherapy . Clin Cancer Res. 3:1997;395-399.
12. Fujii S., Kitano S., Ikenaka K., et al. Effect of coadministration of uracil or cytosine on the antitumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents. Jpn J Cancer Res. 70:1979;209-214.
13. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Jpn J Clin Oncol. 15:1985;559-562.
14. Ikeda K., Saitoh S., Koida I., et al. A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol. 18:1995;204-210.